Label-free immunosensor based on gold nanoparticle silver enhancement

Label-free immunosensor based on gold nanoparticle silver enhancement

Analytical Biochemistry 385 (2009) 128–131 Contents lists available at ScienceDirect Analytical Biochemistry j o u r n a l h o m e p a g e : w w w ...

236KB Sizes 2 Downloads 110 Views

Analytical Biochemistry 385 (2009) 128–131

Contents lists available at ScienceDirect

Analytical Biochemistry j o u r n a l h o m e p a g e : w w w . e l s e v i e r. c o m / l o c a t e / y a b i o

Label-free immunosensor based on gold nanoparticle silver enhancement Minghui Yang a, Cunchang Wang b,* a b

Cen­ter for Advanced Sen­sor Tech­nol­ogy, Uni­ver­sity of Mary­land, Bal­ti­more County, MD 21250, USA Department of Chemistry, Xian­gnan Uni­ver­sity, Chenz­hou 423000, China

a r t i c l e

i n f o

Article history: Received 1 September 2008 Available online 01 November 2008  Key­words: CCD cam­era Gold nano­par­ti­cles Label-free immu­no­sen­sor Sil­ver enhance­ment

a b s t r a c t A label-free immu­no­sen­sor for the sen­si­tive detec­tion of human immu­no­glob­ul­ in G (IgG) was prepared based on gold nano­par­ti­cle–sil­ver enhance­ment detec­tion with a sim­ple charge-cou­pled device (CCD) detec­tor. The gold nano­par­ti­cles, which were used as nuclei for the deposit of metal­lic sil­ver and also for the adsorp­tion of anti­bod­ies, were immo­bi­lized into wells of a 9-well chip. With the addi­tion of sil­ver enhance­ment buffer, metal­lic sil­ver will deposit onto gold nano­par­ti­cles, caus­ing dark­ness that can be opti­cally mea­sured by the CCD cam­era and quan­ti­fied using ImageJ soft­ware. When anti­body was immo­ bi­lized onto the gold nano­par­ti­cles and anti­gen was cap­tured, the formed immu­no­com­plex resulted in a decrease of the dark­ness and the inten­sity of the dark­ness was in line with IgG con­cen­tra­tions from 0.05 to 10 ng/ml. The CCD detec­tor is sim­ple and portable, and the reported method has many desir­able mer­its such as sen­si­tiv­ity and accu­racy, mak­ing it a prom­is­ing tech­nique for pro­tein detec­tion. © 2008 Else­vier Inc. All rights reserved.

Immu­no­sen­sors have been widely stud­ied for clin­i­cal diag­no­ sis, envi­ron­men­tal pol­lu­tant detec­tion, and food anal­y­sis because they are sim­ple, sen­si­tive, and highly selec­tive. Typ­i­cally, anti­gens are selec­tively bound to their com­ple­men­tary anti­bod­ies on a solid sur­face and then to the sec­ond­ary anti­body that is labeled with a probe, which is called the tra­di­tional “sand­wich” assay [1–3]. Dif­ fer­ent probes have been labeled to the sec­ond­ary anti­body with dif­fer­ent detec­tion tech­niques such as enzymes, fluo­res­cent dyes, and nano­par­ti­cles. Enzyme-linked immu­no­sor­bent assay (ELISA)1 is one of the old­est and most widely used lab­o­ra­tory meth­ods used as a diag­nos­tic tool in med­i­cine as well as a qual­ity con­trol check in var­i­ous indus­tries [4–6]. Fluo­res­cence immu­no­as­says are based on anti­bod­ies labeled with fluo­ro­phores; how­ever, the fluo­ ro­phores are eas­ily sub­jected to photo­ble­ach­ing, which may result in reduced accu­racy [7,8]. Recently, nano­par­ti­cles such as gold nano­par­ti­cles and quan­tum dots have been widely used as labels because they are sta­ble and cheap [9–11]. Besides the above-men­tioned tra­di­tional sand­wich assay, labelfree immu­no­sen­sors based on direct detec­tion of anti­body–anti­gen inter­ac­tions have also gained grow­ing inter­est. Park and cowork­ers immo­bi­lized anti­bod­ies on (R)-lipo-di­aza-18-crown-6 self-assem­ bled mono­layer mod­i­fied gold elec­trodes, and the block­ing effect caused by the Ab–Ag adducts formed on elec­trode sur­face resulted in an increased charge trans­fer resis­tance (Rct) of the elec­trode for * Cor­re­spond­ing author. Fax: +86 735 2653013. E-mail address: [email protected] (C. Wang). 1 Abbre­vi­a­tions used: ELISA, enzyme-linked immu­no­sor­bent assay; ECL, elec­tro­ chem­i­lum­in ­ es­cence; CCD, charge-cou­pled device; SEB, staph­y­lo­coc­cal entero­toxin B; IgG, immu­no­glob­u­lin G; BSA, bovine serum albu­min; RSD, rel­a­tive stan­dard devi­a­tion. 0003-2697/$ - see front matter © 2008 Else­vier Inc. All rights reserved. doi:10.1016/j.ab.2008.10.019

a redox probe, which pro­vides a basis for quan­ti­fi­ca­tion of Ag in solu­tion [12]. Jie and cowork­ers immo­bi­lized CdSe nano­crys­tals, car­bon nano­tube, and chito­san com­pos­ite film on elec­trode sur­ face and inves­ti­gated the elec­tro­chem­i­lum­i­nes­cence (ECL) of the film. After anti­body was bound to the film, the spe­cific immu­no­re­ ac­tion between anti­body and anti­gen resulted in a decrease of ECL inten­sity [13]. Sil­ver enhance­ment, a pro­ce­dure for elec­tro­less sil­ver depo­si­ tion where the nano­par­ti­cles act as nuclei, has been widely used for immu­no­as­says [14–16]. In this tech­nique, col­loi­dal metal par­ ti­cles act as cat­a­lysts to reduce sil­ver ions to metal­lic sil­ver, which is typ­i­cally quan­ti­fied by elec­tro­chem­i­cal mea­sure­ment [17] or anodic strip­ping [18]. Exam­ples of immu­no­as­says using col­loi­dal gold nano­par­ti­cles com­bined with sil­ver enhance­ment have been dem­on­strated on micro­arrayed sub­strate [19], between copla­nar elec­trodes [20], and through micro­flu­idic chan­nels [21]. To the best of our knowl­edge, no immu­no­sen­sor based on sil­ver enhance­ment has been reported using a charge-cou­pled device (CCD) cam­era. Pre­vi­ously, our lab reported a car­bon nano­tube-based immu­ no­sen­sor for the detec­tion of staph­y­lo­coc­cal entero­toxin B (SEB) using a CCD cam­era [22]. In the cur­rent arti­cle, we report a novel method for the fab­ri­ca­tion of label-free immu­no­sen­sors using sil­ ver enhance­ment. Gold nano­par­ti­cles were immo­bi­lized in wells of 9-well chips and were used as nuclei for the deposit of metal­lic sil­ ver and also for the immo­bi­li­za­tion of anti­bod­ies. With the for­ma­ tion of anti­body–anti­gen immu­no­com­plex, the amount of metal­lic sil­ver depos­ited onto the nano­par­ti­cles decreased com­pared with that with­out the immu­no­com­plex due to the decreased con­tact of the gold nano­par­ti­cles with sil­ver enhance­ment buffer, The dark­ ness of the wells in accor­dance with the amount of metal­lic sil­ver



Label-free immunosensor / M. Yang, C. Wang / Anal. Biochem. 385 (2008) 128–131

129

was opti­cally mea­sured by a CCD cam­era, and the ­immu­no­sen­sor pro­vided a con­ve­nient, low-cost, sen­si­tive, and spe­cific method for bio­mo­lec­u­lar detec­tion. Mate­ri­als and meth­ods Mate­ri­als and reagents Gold nano­par­ti­cles (G1527, » 0.75 A520 U/ml, 8.5–12.0 nm mean par­ti­cle size [mono­dis­perse], 10 nm par­ti­cle size), goat antihuman immu­no­glob­u­lin G (IgG) anti­body, human IgG anti­gen, and a Sil­ver Enhancer Kit (SE-100) were prod­ucts of Sigma–Aldrich (St. Louis, MO, USA). The Sil­ver Enhancer Kit con­sists of solu­tion A (sil­ ver salt) and solu­tion B (ini­ti­at­ or). Real human blood sam­ples were pro­vided by the Uni­ver­sity of Mary­land Med­i­cal Cen­ter. All other reagents were of ana­lyt­ic­ al grade, and deion­ized water was used through­out. Appa­ra­tus For the CCD-based detec­tion, the schematic con­fig­u­ra­tion of the CCD detec­tor is shown sche­mat­i­cally in Fig. 1A, and Fig. 1B is a pho­to­graph of the actual detec­tion plat­form. The CCD-based detec­ tor con­sists of an enclo­sure and an Atic-16 cooled CCD cam­era or SXVF-M7 (Ad­iron­dack Video Astron­omy, Hud­son Falls, NY, USA). Both cooled CCD cam­eras employ a Sony ICX-429ALL with a 752 £ 582-pixel CCD and are equipped with a 5-mm exten­sion tube and a 12-mm Pen­tax f1.2 lens (Spy­town, Uto­pia, NY, USA). The sys­tem also includes an illu­mi­na­tor. The 9-well sam­ple chips used in this study were designed in Corel­Draw 11 (Co­rel, Ontario, Can­ada) and were mi­croma­chined in 1/8-inch black acrylic using a com­putercon­trolled laser cut­ter (Epi­log Leg­end CO2 65W, Epi­log, Golden, CO, USA). Poly­car­bon­ate film was attached to one side of the chips to hold the chem­i­cal solu­tion (Fig. 1C). The CCD image inten­si­ties were ana­lyzed using ImageJ soft­ware. Prep­a­ra­tion of the immu­no­sen­sor For the prep­a­ra­tion of the immu­no­sen­sor, 15 ll of gold nano­ par­ti­cles was first dropped into the wells of the 9-well chips. When dried, the wells were washed with phos­phate buffer (50 mM, pH 7.4) and 10 ll of 0.1 mg/ml anti­body solu­tion was added into the wells and incu­bated for 1 h. After rins­ing with phos­phate buffer, the chip was incu­bated with 10 ll of 1% bovine serum albu­min (BSA) for 1 h to block non­spe­cific bind­ing sites. Finally, the chip was rinsed and 10 ll of dif­fer­ent con­cen­tra­tions of IgG solu­tion were added into the wells and incu­bated for 45 min. Sil­ver enhance­ment detec­tion For sil­ver enhance­ment detec­tion, 10 ll of sil­ver enhance­ment buffer (mix­ture of the two solu­tions from the Sil­ver Enhancer Kit in a 1:1 vol­ume ratio prepared just prior to use) was added into the wells of the chip, the chip was incu­bated in the dark for 10 min, and then pic­ture was taken by the CCD detec­tor imme­di­ately.

Fig. 1. The CCD detec­tor: (A) schematic con­fig­u­ra­tion of the detec­tor; (B) pho­to­ graph of the actual detec­tion plat­form; (C) actual 9-well sam­ple chip. 1, plas­tic enclo­sure; 2, Atic-16 CCD cam­era [2]. A 5-mm exten­sion tube (3) was attached to the 12-mm Pen­tax f1.2 lens (4). A black acrylic shelf box (5) was designed to hold the sam­ple chip (6) and fluo­res­cence illu­mi­na­tion mod­ule (7).

(sil­ver ions and ini­ti­a­tor) and incu­ba­tion in the dark for 10 min, the pic­ture was taken using the CCD cam­era. Under illu­mi­na­tion, well A appears to be totally white because there was no gold nano­par­ ti­cles and so no metal­lic sil­ver depos­ited and the light from the illu­mi­na­tor was col­lected by the CCD. On the con­trary, in well B, when gold nano­par­ti­cles were intro­duced, the gold nano­par­ti­cles served as nucle­ation sites to cat­a­lyze the reduc­tion of sil­ver ions to metal­lic sil­ver and were enlarged in the pro­cess by up to five orders of mag­ni­tude [16]. As a result, the light from the illu­mi­na­tor was par­tially blocked, dis­play­ing a decrease in light inten­sity. In well C, after immo­bi­li­za­tion of the anti­body and then anti­gen, the light inten­sity increased. The reason was that the formed immu­no­ com­plex after spe­cific immu­no­re­ac­tion greatly inhib­ited the con­ tact of gold nano­par­ti­cles with sil­ver buffer, so that the amount of metal­lic sil­ver depos­ited onto gold sur­face decreased and the light inten­sity was pro­por­tional to the con­cen­tra­tion of anti­gen. The CCD data were quan­ti­fied using ImageJ soft­ware. A cir­cle of 20 pix­els in radius (1250-pixel area) was used as a uniform region of inter­est, which cov­ers roughly 75% of the sur­face of each well of the chip. The value for the indi­vid­ual wells was cal­cu­lated as the aver­age of the inten­sity val­ues of the respec­tive pix­els. After prov­ing the pos­si­bil­ity of using this method to detect the con­cen­tra­tion of IgG, we inves­ti­gated the effect of the sil­ver deposit time. In the wells of the chip, after gold nano­par­ti­cles were immo­bi­lized and sil­ver enhance­ment buffer was added, we tested dif­fer­ent incu­ba­tion times. From Fig. 3A, we can see that with an increase of the incu­ba­tion time from 1 to 5 min, the light inten­ sity of the wells decreased greatly, mean­ing that the amount of metal­lic sil­ver depos­ited increased and so the light inten­sity of

Results and dis­cus­sion In this arti­cle, we have devel­oped a sim­ple method for the prep­ a­ra­tion of label-free immu­no­sen­sor based on sil­ver enhance­ment through detec­tion with a CCD cam­era. First, the pos­si­bil­ity of such a method for the detec­tion of anti­gens was inves­ti­gated. As shown in Fig. 2 for 3 wells of the 9-well chip, well A was blank, well B was immo­bi­lized with only gold nano­par­ti­cles, and well C was immo­bi­lized with gold nano­par­ti­cles and then anti­body–anti­gen immu­no­com­plex. After the addi­tion of sil­ver enhance­ment buffer

Fig. 2. Immunosensor based on sil­ver enhance­ment detec­ted by CCD camera. (A) Blank well. (B) Well immo­bi­lized with only gold nano­par­ti­cles. (C) Well immo­bi­lized with gold nano­par­ti­cles and anti­body–anti­gen immu­no­com­plex. Expo­sure: 1 s.

130

Label-free immunosensor / M. Yang, C. Wang / Anal. Biochem. 385 (2008) 128–131

A 35000 Light intensity

30000 25000 20000 15000 10000 5000 0 0

2

4

6

8

10

12

14

16

B

7000

Light intensity

Time (min)

6500

6000

5500

0

0.1

0.2

0.3

0.4

0.5

0.6

10

12

Antibody concentration (mg/ml)

C Light intensity

8400 7900 7400 6900 6400 0

2

4

6

8

the anti­body load­ing, and then more anti­gens will be cap­tured to form a more “com­pact” film on the gold sur­face to inhibit sil­ver reduc­tion and, as a result, the sen­si­tiv­ity will increase. In fur­ther increas­ing the anti­body con­cen­tra­tion from 0.1 to 0.3 mg/ml, the sen­si­tiv­ity did not change too much, and from 0.3 mg/ml onward increas­ing the anti­body con­cen­tra­tion resulted in a sen­si­tiv­ity decrease. The reason for the decreased sen­si­tiv­ity may be that at a high anti­body con­cen­tra­tion the adsorp­tion of anti­body onto gold sur­face already formed a com­pact film, and so at this time the con­ tact of the gold nano­par­ti­cles with sil­ver enhance­ment buffer was already greatly inhib­ited and fur­ther cap­ture of anti­gen will not help too much of the film to inhibit the con­tact. An anti­body con­ cen­tra­tion of 0.1 mg/ml was used in this exper­i­ment. Dif­fer­ent con­cen­tra­tions of IgG were tested using the 9-well chip to try to draw the cal­i­bra­tion curve. The light inten­sity of the well in the pres­ence of IgG was higher than that in the absence of IgG, and it increased grad­u­ally with the increas­ing con­cen­tra­tions of IgG. The reason was that at higher con­cen­tra­tions of IgG, more IgG mol­ec­ ules were cap­tured by the anti­body, lead­ing to the form­ ing of a more com­pact immu­no­com­plex film. The more com­pact the immu­no­com­plex film, the less con­tact between the gold nano­ par­ti­cles and the sil­ver enhance­ment buffer, and as a result less sil­ ver was depos­ited. So, we can see that the IgG con­cen­tra­tion could be deter­mined by this CCD–sil­ver enhance­ment mea­sure­ment. The stan­dard cal­i­bra­tion curve for the IgG detec­tion is shown in Fig. 3C, and a lin­ear range from 0.05 to 10 ng/ml was obtained. The repro­duc­ibil­ity of the mea­sure­ment was esti­mated. A series of five mea­sure­ments were prepared for the detec­tion of 0.1 and 1 ng/ml IgG. The rel­a­tive stan­dard devi­a­tions (RSDs) of mea­sure­ ment for the 0.1 and 1 ng/ml IgG were 6.1 and 5.7%, respec­tively, sug­gest­ing the reli­abil­ity of the mea­sure­ment. The pos­si­bil­ity of using the method for clin­i­cal appli­ca­tions was inves­ti­gated by detect­ing real sam­ples. Human blood sam­ples were diluted to dif­fer­ent con­cen­tra­tions using phos­phate buffer and were mea­sured using the CCD cam­era fol­low­ing the above meth­ods. The results were com­pared with those of the ELISA method and are shown in Table 1. It can be seen that there is no sig­nif­i­cant dif­fer­ ence between the results obtained by the CCD and ELISA meth­ods, indi­cat­ing that the devel­oped immu­no­as­say method could be used for the deter­mi­na­tion of IgG lev­els in human serum.

Concentration of IgG (ng/ml) Fig. 3. (A) Effect of gold nano­par­ti­cles and sil­ver enhance­ment buffer (10 ll) incu­ ba­tion time on the amount of metal­lic sil­ver depos­ited. (B) Effect of anti­body con­ cen­tra­tion (10 ll) on the sen­si­tiv­ity of the immu­no­sen­sor to 1 ng/ml human IgG. (C) Cal­i­bra­tion curve of the immu­no­sen­sor to dif­fer­ent con­cen­tra­tions of human IgG. The error bars show stan­dard devi­at­ ions (n = 3).

the well decreased. With a fur­ther increase of the time to 10 min, the change in the light inten­sity lev­eled off and after 10 min not too much change was observed. From these results, we can draw the con­clu­sion that after 10 min not too much sil­ver will con­tinue being depos­ited onto the gold nano­par­ti­cles, and so the incu­ba­tion time of 10 min was selected for fur­ther exper­i­ments. Dur­ing the exper­i­ments, we found that the con­cen­tra­tion of anti­body solu­tion affected the sen­si­tiv­ity of the detec­tion. As shown in Fig. 3B, for the detec­tion of 1 ng/ml IgG, when the con­ cen­tra­tion of anti­body solu­tion was increased from 0.01 to 0.1 mg/ ml, the sen­si­tiv­ity increased cor­re­spond­ingly. The reason may be that increas­ing the con­cen­tra­tion of anti­body solu­tion will increase

Table 1 Com­par­i­son of IgG detec­tions on human serum sam­ples by CCD detec­tor and ELISA. Serum sam­ples

1

2

3

4

5

Our method (ng/ml) ELISA (ng/ml)

0.11 0.14

0.53 0.47

0.98 1.08

2.35 2.54

5.68 5.36

Con­clu­sions In this arti­cle, we have reported a novel strat­egy for the fab­ri­ ca­tion of label-free immu­no­sen­sors using a sim­ple and portable CCD detec­tor. The detec­tion scheme is based on gold nano­par­ti­cleinduced sil­ver enhance­ment. With gold nano­par­ti­cles immo­bi­lized into the wells of a 9-well chip, metal­lic sil­ver can be depos­ited onto the gold, caus­ing dark­ness. Pic­tures were taken by the CCD cam­era, and data were quan­ti­fied using ImageJ soft­ware. When anti­body was immo­bi­lized onto the gold nano­par­ti­cles and anti­gen was cap­tured, the formed immu­no­com­plex inhib­ited the con­tact of the gold nano­par­ti­cles with the sil­ver enhance­ment buffer, decreas­ ing the amount of metal sil­ver depos­ited, and the light inten­sity change is in line with IgG con­cen­tra­tions from 0.05 to 10 ng/ml. By com­bin­ing the high sen­si­tiv­ity of CCD–sil­ver enhance­ment mea­ sure­ment with the spec­i­fic­ity of immu­no­re­ac­tion, the devel­oped immu­no­sen­sor was tested for the detec­tion of IgG in human serum sam­ple with sat­is­fac­tory results. This CCD-based detec­tion is sim­ ple, easy, and sen­si­tive, and it could find wide appli­ca­tion in ana­ lyt­i­cal sys­tems and bio­sen­sors. Acknowl­edg­ment We greatly appre­ci­ate the sup­port of the Hunan Pro­vin­cial Nat­ u­ral Sci­ence Foun­da­tion of China (07JJ3017).



Label-free immunosensor / M. Yang, C. Wang / Anal. Biochem. 385 (2008) 128–131

Ref­er­ences [1] S. Vi­swa­na­than, L.C. Wu, M.R. Hu­ang, J.A. Ho, Elec­tro­chem­i­cal immu­no­sen­ sor for chol­era toxin using lip­o­somes and poly(3, 4-eth­yl­ene­di­oxy­thio­phene)coated car­bon nano­tubes, Anal. Chem. 78 (2006) 1115–1121. [2] C.L. Mor­gan, D.J. New­man, C.P. Price, Immu­no­sen­sors: Tech­nol­ogy and oppor­ tu­ni­ties in lab­o­ra­tory med­i­cine, Clin. Chem. 42 (1996) 193–209. [3] D.P. Tang, R. Yuan, Y.Q. Chai, Ultra­sen­si­tive elec­tro­chem­i­cal immu­no­sen­sor for clin­i­cal immu­no­as­say using thi­o­nine-doped mag­netic gold nan­o­spheres as labels and horse­rad­ish per­ox­i­dase as enhancer, Anal. Chem. 80 (2008) 1582– 1588. [4] N. Taka­mune, H. Ha­mad­a, H. Su­gaw­ara, S. Mis­umi, S. Sho­uji, Devel­op­ment of an enzyme-linked immu­no­sor­bent assay for mea­sure­ment of activ­ity of myr­i­ stoyl–coen­zyme A:pro­tein N-myr­i­stoyl­trans­fer­ase, Anal. Bio­chem. 309 (2002) 137–142. [5] V. Ko­uri­lov, M. Stei­nitz, Mag­netic-bead enzyme-linked immu­no­sor­bent assay ver­i­fies adsorp­tion of ligand and epi­tope acces­si­bil­ity, Anal. Bio­chem. 311 (2002) 166–170. [6] M. Stei­nitz, Quan­ti­ta­tion of the block­ing effect of Tween 20 and bovine serum albu­min in ELISA mi­cro­wells, Anal. Bio­chem. 282 (2000) 232–238. [7] G. Mac­be­ath, S.L. Schre­i­ber, Print­ing pro­teins as micro­arrays for high-through­ put func­tion deter­mi­na­tion, Sci­ence 289 (2000) 1760–1763. [8] D.J. Ste­phens, V.J. Allan, Light micros­copy tech­niques for live cell imag­ing, Sci­ ence 300 (2003) 82–86. [9] A.P. Fan, C.W. Lau, J.Z. Lu, Mag­netic bead-based chemi­lu­mi­nes­cent metal immu­no­as­say with a col­loi­dal gold label, Anal. Chem. 77 (2005) 3238– 3243. [10] J. Wang, D. Xu, A. Ka­wde, R. Pol­sky, Metal nano­par­ti­cle-based elec­tro­chem­i­ cal strip­ping poten­ti­o­met­ric detec­tion of DNA hybrid­iza­tion, Anal. Chem. 73 (2001) 5576–5581. [11] M. De­qu­aire, C. De­grand, B. Limoges, An elec­tro­chem­i­cal me­tal­lo­im­mu­no­as­say based on a col­loi­dal gold label, Anal. Chem. 72 (2000) 5521–5528.

131

[12] J.Y. Park, Y.S. Lee, B.H. Kim, S.M. Park, Label-free detec­tion of anti­body–anti­gen inter­ac­tions on (R)-lipo-di­aza-18-crown-6 self-assem­bled mono­layer mod­i­ fied gold elec­trodes, Anal. Chem. 80 (2008) 4986–4993. [13] G.F. Jie, J.J. Zhang, D.C. Wang, C. Cheng, H.Y. Chen, J.J. Zhu, Elec­tro­chem­i­lum­ i­nes­cence immu­no­sen­sor based on CdSe nano­com­pos­ites, Anal. Chem. 80 (2008) 4033–4039. [14] Z.P. Chen, Z.F. Peng, Y. Luo, B. Qu, J.H. Ji­ang, X.B. Zhang, G.L. Shen, R.Q. Yu, Suc­ ces­sively ampli­fied elec­tro­chem­i­cal immu­no­as­say based on bio­cata­lytic depo­ si­tion of sil­ver nano­par­ti­cles and sil­ver enhance­ment, Bio­sens. Bio­elec­tron. 23 (2007) 485–491. [15] Q. Pan, R.Y. Zhang, Y.F. Bai, N.Y. He, Z.H. Lu, An elec­tro­chem­ic­ al approach for detec­tion of spe­cific DNA-bind­ing pro­tein by gold nano­par­ti­cle-cat­a­lyzed sil­ ver enhance­ment, Anal. Bio­chem 375 (2008) 179–186. [16] S. Gupta, S. Huda, P.K. Kil­pa­trick, O.D. Velev, Char­ac­ter­iza­tion and opti­mi­za­ tion of gold nano­par­ti­cle-based sil­ver-enhanced immu­no­as­says, Anal. Chem. 79 (2007) 3810–3820. [17] H. Cai, Y. Wang, P. He, Y. Fang, Elec­tro­chem­i­cal detec­tion of DNA hybrid­iza­tion based on sil­ver-enhanced gold nano­par­ti­cle label, Anal. Chim. Acta 469 (2002) 165–172. [18] X. Chu, X. Fu, K, Chen, G. L. Shen, R. Q. Yu, An elec­tro­chem­i­cal strip­ping me­tal­ lo­im­mu­no­as­say based on sil­ver-enhanced gold nano­par­ti­cle label, Bio­sens. Bio­elec­tron. 20 (2005) 1805–1812. [19] R.Q. Liang, C.Y. Tan, K.C. Ruan, Col­or­i­met­ric detec­tion of pro­tein micro­arrays based on nano­gold probe cou­pled with sil­ver enhance­ment, J. Immu­nol. Meth­ods 285 (2004) 157–163. [20] O.D. Velev, E.W. Kal­er, In situ assem­bly of col­loi­dal par­ti­cles into min­ia­tur­ized bio­sen­sors, Lang­muir 15 (1999) 3693–3698. [21] S.K. Sia, V. Lin­der, B.A. Par­viz, A. Sie­gel, G.M. White­sides, An inte­grated approach to a portable and low-cost immu­no­as­say for resource-poor set­tings, An­gew. Chem. Intl. Ed. 43 (2004) 498–502. [22] M. H. Yang, Y. Kos­tov, H. A. Bruck, A. Raso­ol­y, Car­bon nano­tubes with enhanced chemi­lu­mi­nes­cence immu­no­as­say for CCD-based detec­tion of staph­y­lo­coc­cal entero­toxin B in food, Anal. Chem. in press, doi:10.1021/ac801418n.